Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.

Area of Science:

• Pharmacology
• Materials Science
• Biotechnology

Background:

• Curcumin exhibits poor oral bioavailability due to low absorption.
• Solid lipid nanoparticles (SLNs) offer a promising delivery system for poorly soluble compounds like curcumin.
• Controlling nanoparticle properties is crucial for optimizing drug delivery and therapeutic efficacy.

Purpose of the Study:

• To fabricate polyethylene glycol (PEG)ylated solid lipid nanoparticles (SLNs) for enhanced oral curcumin bioavailability.
• To investigate the impact of emulsifier type and concentration on SLN lipolysis and micelle formation.
• To evaluate the effect of micelle properties on curcumin permeation and in vivo bioavailability.

Main Methods:

• Fabrication of tristearin-based SLNs with varying PEGylated emulsifiers.
• Simulated gastrointestinal digestion to assess lipolysis and micelle formation.
• In vitro assessment of curcumin permeation through mucus-covered gut epithelium.
• In vivo bioavailability study in a rat model.

Main Results:

• >91% curcumin bioaccessibility was achieved from all SLNs after simulated digestion.
• Curcumin permeation across gut epithelium was dependent on micelle size and surface charge.
• Long-PEGylated SLNs formed neutral micelles, enhancing curcumin permeation and achieving >12.0-fold increased bioavailability in rats.

Conclusions:

• Oral bioavailability of curcumin can be effectively controlled by modulating the interfacial properties of SLNs.
• PEGylated SLNs, particularly those with long PEG chains, show significant potential for improving curcumin delivery.
• This approach facilitates the development of advanced curcumin formulations for functional foods and pharmaceuticals.